FDMTNasdaq United States
Market cap
$561.970 M
$10.75 +1.90%
Close of 7 Aug 2026
Revenue
$85.2M
#2573 by revenue
Earnings
-$140.1M
Loss-making
Shares outstanding
52,271,648
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for 4D Molecular Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.